Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
J Neurol Neurosurg Psychiatry
.
2014 May;85(5):589-90.
doi: 10.1136/jnnp-2013-306541.
Epub 2013 Nov 29.
Authors
Joanna Kitley
1
,
M Isabel Leite
,
Liene Elsone
,
Anu Jacob
,
Jackie Palace
Affiliation
1
Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, , Oxford, UK.
PMID:
24292996
DOI:
10.1136/jnnp-2013-306541
No abstract available
Keywords:
Multiple Sclerosis; Myelopathy; Neuroimmunology.
Publication types
Letter
MeSH terms
Disease-Free Survival
Humans
Neuromyelitis Optica / etiology
Neuromyelitis Optica / therapy*
Recurrence
Time Factors